Newer Diabetes Drugs Cost More, But May Not Work Better, University of Michigan, Mayo Clinic And North Carolina State University Study
Published: Feb 28, 2014
Two newer classes of drugs to treat adult-onset diabetes may be no more effective than the old standby, yet they cost significantly more over the course of a patient’s disease. That’s according to a National Science Foundation-funded study by researchers at the University of Michigan, Mayo Clinic and North Carolina State University.
Hey, check out all the research scientist jobs. Post your resume today!